[go: up one dir, main page]

GB202311858D0 - Methods and compositions - Google Patents

Methods and compositions

Info

Publication number
GB202311858D0
GB202311858D0 GBGB2311858.1A GB202311858A GB202311858D0 GB 202311858 D0 GB202311858 D0 GB 202311858D0 GB 202311858 A GB202311858 A GB 202311858A GB 202311858 D0 GB202311858 D0 GB 202311858D0
Authority
GB
United Kingdom
Prior art keywords
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2311858.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xap Therapeutics Ltd
Xap Therapeutics Ltd
Original Assignee
Xap Therapeutics Ltd
Xap Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xap Therapeutics Ltd, Xap Therapeutics Ltd filed Critical Xap Therapeutics Ltd
Priority to GBGB2311858.1A priority Critical patent/GB202311858D0/en
Publication of GB202311858D0 publication Critical patent/GB202311858D0/en
Priority to PCT/GB2024/052048 priority patent/WO2025027344A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
GBGB2311858.1A 2023-08-02 2023-08-02 Methods and compositions Ceased GB202311858D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2311858.1A GB202311858D0 (en) 2023-08-02 2023-08-02 Methods and compositions
PCT/GB2024/052048 WO2025027344A1 (en) 2023-08-02 2024-08-01 Compositions comprising gpcr based chimeric antigen receptor and methods of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2311858.1A GB202311858D0 (en) 2023-08-02 2023-08-02 Methods and compositions

Publications (1)

Publication Number Publication Date
GB202311858D0 true GB202311858D0 (en) 2023-09-13

Family

ID=87929933

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2311858.1A Ceased GB202311858D0 (en) 2023-08-02 2023-08-02 Methods and compositions

Country Status (2)

Country Link
GB (1) GB202311858D0 (en)
WO (1) WO2025027344A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001257169C1 (en) * 2000-04-21 2011-06-16 Tufts Medical Center, Inc. G-protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
GB201609604D0 (en) * 2016-06-01 2016-07-13 Ucl Business Plc Cell
GB202108585D0 (en) 2021-06-16 2021-07-28 Rockend Ltd Methods and compositions

Also Published As

Publication number Publication date
WO2025027344A1 (en) 2025-02-06

Similar Documents

Publication Publication Date Title
GB202111040D0 (en) Compositions and methods
GB202108585D0 (en) Methods and compositions
GB202004677D0 (en) Methods and compositions
GB202316199D0 (en) Compositions and methods and uses thereto
GB202411091D0 (en) Compositions and uses
IL304824A (en) Fospropofol methods and compositions
GB202217944D0 (en) Compositions and method
GB202110091D0 (en) Methods and compositions
IL321428A (en) Compositions and methods
GB202316109D0 (en) Methods and compositions
GB202316106D0 (en) Methods and compositions
GB202311858D0 (en) Methods and compositions
GB202308901D0 (en) Methods and compositions
GB202307563D0 (en) Methods and compositions
GB202305427D0 (en) Methods and compositions
GB202304240D0 (en) Compositions and methods
IL315882A (en) Anti-ilt4 compositions and methods
GB202219851D0 (en) Compositions and methods
GB202209588D0 (en) Methods and compositions
GB202209115D0 (en) Compositions and methods
GB202206268D0 (en) Compositions and methods
GB202205579D0 (en) Methods and compositions
GB202306393D0 (en) Trna-based methods and related compositions
GB202409672D0 (en) compositions and methods and uses related thereto
GB202406838D0 (en) Compositions and methods and uses related thereto

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)